Thompson Davis & Co’s SurgePays SURG Stock Holding History

Thompson Davis & Co’s Portfolio SURG Stock Details SURG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-57,580	Closed	-$421K	–	134
2023 Q2	$421K	Buy	+57,580	New	+$343K	0.48%	40

Other funds holding SURG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Praetorian PR Rincon, Puerto Rico $275M AUM 84.95% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Davis & Co's SURG Position: Q3 2023 in Review

Thompson Davis & Co sold out of SurgePays (SURG) in Q3 2023, closing a stake of 57,580 shares — an estimated $421K sold.

Thompson Davis & Co first reported a position in SURG in Q2 2023 and held it in 1 quarter. The position peaked at $421K in Q2 2023. 28 funds tracked by Wall St. Rank hold SURG as of Q3 2023.

Thompson Davis & Co reported no remaining SurgePays position as of Q3 2023 after selling out during the quarter.
Thompson Davis & Co sold 57,580 SurgePays shares in Q3 2023, an estimated $421K.
Thompson Davis & Co first reported a position in SurgePays in Q2 2023 and held it in 1 quarter.
Thompson Davis & Co's SurgePays position peaked at $421K in Q2 2023.
28 funds tracked by Wall St. Rank held SurgePays as of Q3 2023.

Based on Thompson Davis & Co's 13F filing for Q3 2023, filed 9 Nov 2023.